EGFR and KRAS mutation analysis in cytologic samples of lung adenocarcinoma enabled by laser capture microdissection

The discovery of activating mutations in EGFR and KRAS in a subset of lung adenocarcinomas was a major advance in our understanding of lung adenocarcinoma biology, and has led to groundbreaking studies that have demonstrated the efficacy of tyrosine kinase inhibitor therapy. Fine-needle aspirates an...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Mod Pathol
Prif Awduron: Chowdhuri, Sinchita Roy, Xi, Liqiang, Pham, Trinh Hoc-Tran, Hanson, Jeffrey, Rodriguez-Canales, Jaime, Berman, Arlene, Rajan, Arun, Giaccone, Giuseppe, Emmert-Buck, Michael, Raffeld, Mark, Filie, Armando C
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2011
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7470622/
https://ncbi.nlm.nih.gov/pubmed/22157931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/modpathol.2011.184
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg